Nrf2-related pathogenesis of premature ovarian insufficiency and traditional Chinese medicine-based interventions

Premature ovarian insufficiency (POI) is a complex reproductive disorder characterized by diminished ovarian reserve and impaired ovarian endocrine function before the age of 40 years. Increasing evidence indicates that oxidative stress plays a pivotal role in POI pathogenesis by inducing mitochondrial dysfunction, DNA damage, inflammatory responses, ferroptosis, and granulosa cell apoptosis, ultimately accelerating follicular depletion. Nuclear factor erythroid 2-related factor 2 (Nrf2), a master regulator of cellular antioxidant defense, is essential for maintaining ovarian redox homeostasis and protecting reproductive function. Recent advances have demonstrated that traditional Chinese medicine (TCM), including herbal medicines, bioactive metabolites, classical formulations, and acupuncture therapies, exerts protective effects against POI by modulating Nrf2-associated signaling networks, thereby enhancing antioxidant enzyme expression, improving mitochondrial function, reducing oxidative DNA damage, suppressing inflammation and apoptosis, and preserving follicular development. This review summarizes the pathological role of oxidative stress and Nrf2 signaling in POI, and discusses the current progress of TCM interventions modulating the Nrf2 pathway, including their molecular mechanisms and therapeutic potential. Furthermore, the limitations of current research, including the lack of clinically representative models, limited understanding of molecular targets, and insufficient evidence from well-designed clinical studies, are highlighted. Future studies integrating multi-omics approaches, precision medicine, and evidence-based clinical trials are warranted to further elucidate the regulatory networks of TCM-mediated Nrf2 activation and promote the clinical translation of TCM strategies for POI prevention and treatment.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-09
DOI
https://doi.org/10.3389/fphar.2026.1958737
Primary Topic
Reproductive Biology and Fertility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Nrf2-related pathogenesis of premature ovarian insufficiency and traditional Chinese medicine-based interventions

Xinwu Zheng, Kaifeng Yang, Meiqiao Wang, Bin Zhou et al.
Frontiers in Pharmacology
Reproductive Biology and Fertility
article

Nrf2-related pathogenesis of premature ovarian insufficiency and traditional Chinese medicine-based interventions

Xinwu Zheng, Kaifeng Yang, Meiqiao Wang, Bin Zhou, Lan Li
article en

Abstract

Premature ovarian insufficiency (POI) is a complex reproductive disorder characterized by diminished ovarian reserve and impaired ovarian endocrine function before the age of 40 years. Increasing evidence indicates that oxidative stress plays a pivotal role in POI pathogenesis by inducing mitochondrial dysfunction, DNA damage, inflammatory responses, ferroptosis, and granulosa cell apoptosis, ultimately accelerating follicular depletion. Nuclear factor erythroid 2-related factor 2 (Nrf2), a master regulator of cellular antioxidant defense, is essential for maintaining ovarian redox homeostasis and protecting reproductive function. Recent advances have demonstrated that traditional Chinese medicine (TCM), including herbal medicines, bioactive metabolites, classical formulations, and acupuncture therapies, exerts protective effects against POI by modulating Nrf2-associated signaling networks, thereby enhancing antioxidant enzyme expression, improving mitochondrial function, reducing oxidative DNA damage, suppressing inflammation and apoptosis, and preserving follicular development. This review summarizes the pathological role of oxidative stress and Nrf2 signaling in POI, and discusses the current progress of TCM interventions modulating the Nrf2 pathway, including their molecular mechanisms and therapeutic potential. Furthermore, the limitations of current research, including the lack of clinically representative models, limited understanding of molecular targets, and insufficient evidence from well-designed clinical studies, are highlighted. Future studies integrating multi-omics approaches, precision medicine, and evidence-based clinical trials are warranted to further elucidate the regulatory networks of TCM-mediated Nrf2 activation and promote the clinical translation of TCM strategies for POI prevention and treatment.

Frontiers in PharmacologyVol. 17
Hainan Vocational University of Science and Technology (CN)
Reproductive Biology and Fertility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Nrf2-related pathogenesis of premature ovarian insufficiency and traditional Chinese medicine-based interventions — Xinwu Zheng, Kaifeng Yang, et al. · Frontiers in Pharmacology (2026) | TGRS Research Map | TGRS